ORTHOCORD ONE VIOLET AND ONE BLUE BRAIDED COMPOSITE SUTURE 2 (5 METRIC), Catalog Number: 223113....
FDA Device Recall #Z-1173-2013 — Class II — March 22, 2013
Recall Summary
| Recall Number | Z-1173-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 22, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | DePuy Mitek, Inc., a Johnson & Johnson Co. |
| Location | Raynham, MA |
| Product Type | Devices |
| Quantity | 84174 |
Product Description
ORTHOCORD ONE VIOLET AND ONE BLUE BRAIDED COMPOSITE SUTURE 2 (5 METRIC), Catalog Number: 223113. For use in general soft tissue approximation, and/or ligation, including orthopedic procedures.
Reason for Recall
The IFU provided with the free strand ORTHOCORD sutures currently indicates that approximately 100% suture strength remains at six weeks after implantation. While this statement is true for Violet ORTHOCORD sutures, it is an inaccurate statement for Blue ORTHOCORD free strand sutures. Based on in-vivo strength retention study, a Blue ORTHOCORD sutures maintain approximately 80% of strength at six
Distribution Pattern
Nationwide Distribution.
Lot / Code Information
ALL from Jan 1 2010 - Corrected IFU implementation date
Other Recalls from DePuy Mitek, Inc., a Johnson & Johnso...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1314-2025 | Class II | COR Disposable Kit, 8 mm. Cartilage Transplant ... | Feb 24, 2025 |
| Z-1315-2025 | Class II | COR Disposable Kit, 8 mm w/ Perpendicularity. C... | Feb 24, 2025 |
| Z-1678-2023 | Class II | DePuy Mitek BIOKNOTLESS Plus w/ Panacryl-Indica... | Apr 13, 2023 |
| Z-1679-2023 | Class II | DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated fo... | Apr 13, 2023 |
| Z-1680-2023 | Class II | DePuy Mitek BIOKNOTLESS Rapid W/ OC-Indicated f... | Apr 13, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.